119 related articles for article (PubMed ID: 22589256)
1. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.
Carmona FD; Serrano A; Rodríguez-Rodríguez L; Callejas JL; Simeón CP; Carreira P; Castañeda S; Solans R; Blanco R; ; ; González-Gay MA; Martín J
J Rheumatol; 2012 Jun; 39(6):1275-9. PubMed ID: 22589256
[TBL] [Abstract][Full Text] [Related]
2. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.
Carmona FD; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Marí-Alfonso B; Unzurrunzaga A; Ríos-Fernández R; Blanco R; de Miguel E; Martín J; González-Gay MA
Hum Immunol; 2011 May; 72(5):458-61. PubMed ID: 21354457
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis.
Palomino-Morales R; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Ortego-Centeno N; Miranda-Filloy JA; Lamas JR; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 May; 36(5):1021-5. PubMed ID: 19332627
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis.
Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Ortego-Centeno N; Gonzalez-Alvaro I; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2010 Jan; 37(1):131-5. PubMed ID: 19918040
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Oliver J; Orozco G; Garcia-Porrua C; Lopez-Nevot MA; Martin J
J Rheumatol; 2005 Aug; 32(8):1510-2. PubMed ID: 16078327
[TBL] [Abstract][Full Text] [Related]
8. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
Alizadeh BZ; Broen J; Rueda B; Hesselstrand R; Wuttge D; Simeon C; Ortego-Centeno N; Gonzalez-Gay MA; Pros A; Herrick A; Worthington J; Denton C; Fonseca C; Riemekasten G; Vonk MC; van den Hoogen F; Guiducci S; Matucci-Cerinic M; Scorza R; Beretta L; Airó P; Coenen M; Martin J; Koeleman BP; Radstake TR;
J Rheumatol; 2010 Aug; 37(8):1673-9. PubMed ID: 20551103
[TBL] [Abstract][Full Text] [Related]
9. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
[TBL] [Abstract][Full Text] [Related]
10. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
Palomino-Morales R; Torres O; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Callejas-Rubio JL; Miranda-Filloy JA; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 Jul; 36(7):1501-6. PubMed ID: 19531762
[TBL] [Abstract][Full Text] [Related]
11. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.
Carmona FD; Serrano A; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Solans R; Sopeña B; Marí-Alfonso B; Unzurrunzaga A; Ortego-Centeno N; Blanco R; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA
J Rheumatol; 2011 Dec; 38(12):2598-601. PubMed ID: 21965647
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.
Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Valero F; Callejas-Rubio JL; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2010 Jan; 37(1):136-40. PubMed ID: 19918036
[TBL] [Abstract][Full Text] [Related]
13. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni PL; Cimino L; Bajocchi GL; Catanoso MG; Pattacini L; Ghinoi A; Restuccia G; Boiardi L
Ann Rheum Dis; 2008 Apr; 67(4):485-8. PubMed ID: 17704068
[TBL] [Abstract][Full Text] [Related]
14. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promoter polymorphisms in giant cell arteritis.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Pattacini L; Salvarani C
Arthritis Rheum; 2006 Dec; 54(12):4011-7. PubMed ID: 17133531
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Amoli MM; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2005 Jan; 32(1):74-6. PubMed ID: 15630728
[TBL] [Abstract][Full Text] [Related]
18. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
[TBL] [Abstract][Full Text] [Related]
19. Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis.
Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Ortego-Centeno N; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
Hum Immunol; 2010 May; 71(5):525-9. PubMed ID: 20156505
[TBL] [Abstract][Full Text] [Related]
20. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
